Cargando…

Targeted Metabolomics Finds Its Mark in Diabetes Research

Detalles Bibliográficos
Autor principal:	Bain, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554350/ https://www.ncbi.nlm.nih.gov/pubmed/23349543 http://dx.doi.org/10.2337/db12-1189

Ejemplares similares

Metabolomics Makes a Mark: Early Changes Associated With Autoimmune Diabetes
por: Leslie, R. David, et al.
Publicado: (2011)

Metabolomics Reveals Unexpected Responses to Oral Glucose
por: Bain, James R., et al.
Publicado: (2013)

"Cullin 4 makes its mark on chromatin"
por: Dai, Qian, et al.
Publicado: (2006)

History Leaves Its Mark on Soil Bacterial Diversity
por: Martiny, Jennifer B. H.
Publicado: (2016)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Summative peer marking?
por: O’Neill, Lotte, et al.
Publicado: (2016)

Bite mark evidence: bite mark analysis is not the same as bite mark comparison or matching or identification
por: Souviron, Richard, et al.
Publicado: (2017)

“Prediction Is Very Hard, Especially About the Future”: New Biomarkers for Type 2 Diabetes?
por: Lowe, William L., et al.
Publicado: (2013)

Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge
por: Bain, James R., et al.
Publicado: (2009)

Bearing the mark of pain: mystery in medicine
por: Celie, Karel-Bart, et al.
Publicado: (2023)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

Epigenetic changes during sepsis: on your marks!
por: Bataille, Aurélien, et al.
Publicado: (2015)

Recognizing the value of meta-research and making it easier to find
por: Stevens, Elizabeth R., et al.
Publicado: (2023)

Metabolomics, Stable Isotopes, and A(−)β(+) Ketosis-Prone Diabetes
por: Ramos-Roman, Maria A., et al.
Publicado: (2013)

HIV research in Australia: linking basic research findings with clinical and public health outcomes
por: Lewin, Sharon R, et al.
Publicado: (2006)

Granzyme B; the chalk-mark of a cytotoxic lymphocyte
por: Waterhouse, Nigel J, et al.
Publicado: (2004)

Commentary: That's going to leave a mark, but how big?
por: Engelhardt, Kathryn E., et al.
Publicado: (2021)

Commentary: Missing the mark but we must keep trying
por: Vo, Thin X., et al.
Publicado: (2020)

The bane of publishing a research article in international journals by African researchers, the peer-review process and the contentious issue of predatory journals: a commentary
por: Tarkang, Elvis Enowbeyang, et al.
Publicado: (2019)

Implications of the Global Early Adolescent Study's Formative Research Findings for Action and for Research
por: Chandra-Mouli, Venkatraman, et al.
Publicado: (2017)

The Juvenile Diabetes Research Foundation at Forty: Updates of Research in Type 1 Diabetes
por: Nierras, Concepcion R., et al.
Publicado: (2010)

Radiographic findings in tuberculous diabetic patients
por: Singh, Akashdeep
Publicado: (2011)

Commentary: Moving towards “mark-less” toric IOL alignment
por: Titiyal, Jeewan S, et al.
Publicado: (2020)

Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy
por: Riddell, Stanley R.
Publicado: (2004)

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2021)

Social and Political Dimensions of Disseminating Research Findings on Emerging Zoonotic Viruses: Our Experience in Sierra Leone
por: Peprah, Dorothy, et al.
Publicado: (2021)

Overcoming challenges to dissemination and implementation of research findings in under-resourced countries
por: Derman, Richard J., et al.
Publicado: (2018)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Metabolomics, stunting and neurodevelopment
por: van den Heuvel, Meta
Publicado: (2019)

Metabolomics for the diagnosis of influenza
por: Burgess, Karl, et al.
Publicado: (2021)

Commentary: Finding a solution to the problem: Innovation at its finest
por: Pagani, Francis D.
Publicado: (2021)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Cancer cells, on your histone marks, get SETDB1, silence retrotransposons, and go!
por: Robbez-Masson, Luisa, et al.
Publicado: (2017)

Finding Needles in Haystacks and Inferring Their Function: Challenges and Successes in Beneficial Symbiosis Research
por: Bennett, Gordon M., et al.
Publicado: (2021)

Glycogen Synthase Kinase-3β and Cathepsin B in Diabetic Endothelial Progenitor Cell Dysfunction: An Old Player Finds a New Partner
por: Muniyappa, Ranganath, et al.
Publicado: (2014)

HIV self-testing: finding its way in the prevention tool box
por: Ortblad, Katrina F., et al.
Publicado: (2020)

Retinal disease: How to use proteomics to speed up diagnosis and metabolomics to slow down degeneration
por: Hurley, James B., et al.
Publicado: (2020)

The mesenchymal stromal cell magic bullet finds yet another target
por: Masterson, Claire, et al.
Publicado: (2014)

Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
por: Fischer, Benedikt, et al.
Publicado: (2023)

UNAIDS 90–90–90 targets to end the AIDS epidemic by 2020 are not realistic: comment on “Can the UNAIDS 90–90–90 target be achieved? A systematic analysis of national HIV treatment cascades”
por: Bain, Luchuo Engelbert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4b5g5lpgg9k4g1vd13n9i34g71